Medicenna Therapeutics Corp. Gains Losses On Change In Fair Value Of Derivatives
Medicenna Therapeutics Corp. (MDNAF) reported Gains Losses On Change In Fair Value Of Derivatives of CAD 4.35 million for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives · last filed 2023-06-27
| Period end | Gains Losses On Change In Fair Value Of Derivatives 8 month | Gains Losses On Change In Fair Value Of Derivatives 12 month |
|---|---|---|
| 2023-03-31 | -4.82M CAD 20-F · filed 2023-06-27 | 4.35M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 0.00 CAD 20-F · filed 2023-06-27 | |
| 2021-03-31 | 0.00 CAD 20-F · filed 2023-06-27 |